✦ LIBER ✦

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

✍ Scribed by Gordon, Stuart C.; Krastev, Zahary; Horban, Andrzej; Petersen, Jörg; Sperl, Jan; Dinh, Phillip; Martins, Eduardo B.; Yee, Leland J.; Flaherty, John F.; Kitrinos, Kathryn M.; Rustgi, Vinod K.; Marcellin, Patrick

Book ID: 120278342
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 817 KB
Volume: 58
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.26277

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Comparison of Tenofovir Disop

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

✍ Fung, Scott; Kwan, Peter; Fabri, Milotka; Horban, Andrzej; Pelemis, Mijomir; Han 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 639 KB

Sa1046 Efficacy of 5 Years of Tenofovir

Sa1046 Efficacy of 5 Years of Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B Patients With High Viral Load (HBV DNA =9 Log10 Copies/Ml)

✍ Gordon, Stuart C.; Marcellin, Patrick; Krastev, Zahary; Horban, Andrzej; Peterse 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Comparison of the Efficacy of Entecavir

Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B Patients With High Viral Load and/or High Fibrosis Scores at Week 48 of Therapy

✍ Kurdas Ovunc, Ayse O. ;Guzelbulut, Fatih ;Senates, Ebubekir ;Gökden, Yasemin ;De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 588 KB

No resistance to tenofovir disoproxil fu

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

✍ Andrea Snow-Lampart; Brandi Chappell; Maria Curtis; Yuao Zhu; Florence Myrick; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Tenofovir disoproxil fumarate (TDF) is a nucleotide analogue with potent activity against human immunodeficiency virus type 1 and hepatitis B virus (HBV). To date, no reports of HBV clinical resistance to TDF have been confirmed. In two phase 3 studies (GS-US-174-0102 and GS-US-174-0103), 375 hepati

No detectable resistance to tenofovir di

No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B

✍ Kitrinos, Kathryn M.; Corsa, Amoreena; Liu, Yang; Flaherty, John; Snow-Lampart, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

Efficacy and tolerance of a combination

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study

✍ Si-Nafa Si-Ahmed; Pierre Pradat; Roeland Zoutendijk; Maria Buti; Vincent Mallet; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 521 KB